Acumen Pharmaceuticals (ABOS) Other Accumulated Expenses (2020 - 2022)

Acumen Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $37000.0 for Q3 2022.

• In Q3 2022, Other Accumulated Expenses fell 68.91% year-over-year to $37000.0; the TTM figure through Sep 2022 stood at $37000.0 (down 68.91% YoY), while the FY2021 annual figure was $204000.0, up 126.67% from the prior year.
• Other Accumulated Expenses came in at $37000.0 for Q3 2022 at Acumen Pharmaceuticals, down from $101000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $204000.0 in Q4 2021 to a low of $37000.0 in Q3 2022.
• A 3-year average of $100285.7 and a median of $99000.0 in 2022 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 126.67% in 2021 and tumbled 68.91% in 2022, its largest moves.
• Acumen Pharmaceuticals' Other Accumulated Expenses stood at $90000.0 in 2020, then jumped by 126.67% to $204000.0 in 2021, then tumbled by 81.86% to $37000.0 in 2022.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $37000.0, $101000.0, and $99000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison